Gamma-2 herpesviruses are associated with tumors in immunosuppressed hosts. Kaposi sarcoma, the most frequent malignancy in AIDS, correlates with infection by human herpesvirus 8 (KSHV, HHV8). To establish lifelong infections in immunocompetent individuals, it is essential for all herpesviruses to strike a balance between immune control and immune evasion. Major histocompatibility complex class I (MHC I) antigen presentation is frequently targeted by viral counter mechanisms to escape cytotoxic T cell control. Our long-term goal is to understand how pathogens thwart this pathway. Previously, we characterized evasion strategies used by alpha and beta herpesviruses. However, KSHV seems to dowregulate MHC I in a novel and unique way by expressing two viral proteins, K3 and K5, residing in the membrane of the endoplasmic reticulum. In contrast, MHC I molecules travel to the cell surface where they are rapidly internalized and degraded in intracellular vesicles. Several lines of evidence are consistent with a mechanism whereby the viral proteins modify the cytoplasmic tail of MHC I by transiently interacting in the ER. This post-translational modification, presumed to be ubiquitination, could then serve as an internalization signal at the cell surface. We will test this hypothesis by characterizing the structural motifs and post-translational modifications of MHC I molecules and by studying their interaction with the viral proteins. The aminoterminal region of K3 and K5 contains a conserved PHD/LAP finger that is essential for MHC downregulation. Current evidence suggests that the PHD-domains interact with cellular proteins. Using several different aprpoaches, we will search for these cellular interacting partners. Open reading frames, homologous to K3 and K5, can be found across the gamma-2 herpesvirus family. Importantly, the homologous gene, K3, of murine gamma herpesvirus 68 (MHV68) was also shown to downregulate MHC I. Moreover, K3-deleted virus is deficient in maintaining latency. This model can thus be used to explore if KSHV-K3 or K5 can restore pathogenesis of K3-deleted MHV68. We expect the results of our experiments to have an impact on the understanding of the cell biology, immunology and pathogenesis of infections by gamma-2 herpesviridae.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA094011-01A1
Application #
6542914
Study Section
Virology Study Section (VR)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
2002-08-01
Project End
2007-07-31
Budget Start
2002-08-01
Budget End
2003-07-31
Support Year
1
Fiscal Year
2002
Total Cost
$302,378
Indirect Cost
Name
Oregon Health and Science University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Viswanathan, Kasinath; Smith, M Shane; Malouli, Daniel et al. (2011) BST2/Tetherin enhances entry of human cytomegalovirus. PLoS Pathog 7:e1002332
Bartee, Eric; Eyster, Craig A; Viswanathan, Kasinath et al. (2010) Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes. PLoS One 5:e15132
Viswanathan, Kasinath; Früh, Klaus; DeFilippis, Victor (2010) Viral hijacking of the host ubiquitin system to evade interferon responses. Curr Opin Microbiol 13:517-23
Douglas, Janet L; Viswanathan, Kasinath; McCarroll, Matthew N et al. (2009) Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J Virol 83:7931-47
Mansouri, Mandana; Viswanathan, Kasinath; Douglas, Janet L et al. (2009) Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J Virol 83:9672-81
Pantanowitz, Liron; Fruh, Klaus; Marconi, Sharon et al. (2008) Pathology of rituximab-induced Kaposi sarcoma flare. BMC Clin Pathol 8:7
Thibodeau, Jacques; Bourgeois-Daigneault, Marie-Claude; Huppe, Gabrielle et al. (2008) Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur J Immunol 38:1225-30
Viswanathan, Kasinath; Fruh, Klaus (2007) Viral proteomics: global evaluation of viruses and their interaction with the host. Expert Rev Proteomics 4:815-29
Rose, Patrick P; Bogyo, Matthew; Moses, Ashlee V et al. (2007) Insulin-like growth factor II receptor-mediated intracellular retention of cathepsin B is essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. J Virol 81:8050-62
Mansouri, Mandana; Douglas, Janet; Rose, Patrick P et al. (2006) Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Blood 108:1932-40

Showing the most recent 10 out of 12 publications